Business Description
ImmunityBio Inc
NAICS : 541714
SIC : 8731
ISIN : US45256X1037
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.3 | |||||
Equity-to-Asset | -1.57 | |||||
Debt-to-Equity | -1.05 | |||||
Debt-to-EBITDA | -1.69 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -11.78 | |||||
Beneish M-Score | -3.01 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | -17.2 | |||||
3-Year EPS without NRI Growth Rate | -24 | |||||
3-Year FCF Growth Rate | -19.9 | |||||
3-Year Book Growth Rate | -40.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 23.46 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 681.15 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.97 | |||||
9-Day RSI | 31.78 | |||||
14-Day RSI | 32.03 | |||||
6-1 Month Momentum % | -18.59 | |||||
12-1 Month Momentum % | 129.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.91 | |||||
Quick Ratio | 3.88 | |||||
Cash Ratio | 3.51 | |||||
Days Sales Outstanding | 288.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.5 | |||||
Shareholder Yield % | -1.05 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -27459.33 | |||||
Net Margin % | -45691.67 | |||||
FCF Margin % | -32429.24 | |||||
ROA % | -144.14 | |||||
ROIC % | -106.43 | |||||
3-Year ROIIC % | -150.96 | |||||
ROC (Joel Greenblatt) % | -247.1 | |||||
ROCE % | -190 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1745 | |||||
EV-to-EBIT | -6.49 | |||||
EV-to-EBITDA | -6.76 | |||||
EV-to-Revenue | 2254.22 | |||||
EV-to-FCF | -6.93 | |||||
Earnings Yield (Greenblatt) % | -15.41 | |||||
FCF Yield % | -17.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ImmunityBio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.214 | ||
EPS (TTM) (€) | -0.896 | ||
Beta | -0.88 | ||
Volatility % | 132.15 | ||
14-Day RSI | 32.03 | ||
14-Day ATR (€) | 0.14795 | ||
20-Day SMA (€) | 3.4331 | ||
12-1 Month Momentum % | 129.62 | ||
52-Week Range (€) | 1.18 - 9.094 | ||
Shares Outstanding (Mil) | 696.53 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ImmunityBio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ImmunityBio Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
ImmunityBio Inc Frequently Asked Questions
What is ImmunityBio Inc(STU:26CA)'s stock price today?
When is next earnings date of ImmunityBio Inc(STU:26CA)?
Does ImmunityBio Inc(STU:26CA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |